The Role of Low Level Laser Therapy
   in the Medical Management of
       Androgenetic Alopecia


             Alan J. Bauman, M.D.
 Diplomate, American and Int’l Board of Hair Restoration Surgery


European Masters in Aesthetic & Anti-Aging Medicine
   2nd International Hair Surgery Masters Course
          October 13th, 2012 Paris, France
Disclosures
The following conflicts of interest are germane to my presentation: NONE




                   LaserSpa at Bauman Medical Group
Alan J. Bauman, M.D.
Bauman Medical Group – Boca Raton, FL (1997)
New York Medical College
Beth Israel Medical Center – NY
Mt. Sinai Medical Center – NY
Hair Transplantation – NY
American Bd of Hair Restoration Surgery
American Hair Loss Association
Low Level Laser Therapy (1999)
Overview
  Androgenetic Alopecia

  Mechanisms of Laser Therapy (LLLT)

  Role of LLLT in Hair Restoration

  Laser Therapy Dosing Protocol

  Our Experience w/ Laser Therapy

  Practical Concerns
Androgenetic Alopecia
Hereditary : ♀♂                           HAIR LOSS CAUSES
Androgen Receptors                          4%
Progressive                                          AGA
Patterned hair follicle miniaturization              Other

Shorter/Finer/Thinner/Less Pigmented               96%
Androgenetic Alopecia
      Multi-Therapy Medical Management
Eliminate/Reduce ‘Triggers’
•   Medical conditions, meds, social
    habits, nutrition, stress, etc.

↓DHT production and/or Androgen Effects
•   Finasteride, Dutasteride*, Spironolactone*

Stimulate Hair Follicles
•   2%, 5%, 6%* Minoxidil, 0.03% Bimatoprost*,
•   Laser Therapy, Phototherapy, PRP

Redistribute (Transplant) Permanent Follicles
•   NeoGraft / FUE – no linear scar

Surgically Reduce/Remove Bald Areas
•   Scalp Reduction/Flaps



                                                 *off-label
Low Level Laser Therapy
 < 500 mW (5mW)
                              Non-chemical
 630-670nm (650nm)
                              Non-invasive

                              Non-cutting/burning

                              Non-thermal

   3,000 papers               No side-effects

   8 textbooks                Photobiomodulation
   6 societies
   2 peer-reviewed journals
Phototherapy/LLLT Concepts




Mechanism:
     Cytochrome–C–Oxidase
     ↑ATP production
     Non-ionizing
     Non-thermal
     No side-effects
                            Tuner J/Hode L, Laser Therapy, (2004) Prima Books
growth factor production
                            extracellular matrix deposition
      near infrared light
                            cell proliferation & motility
                            anti-apoptosis and pro-survival

                                             Gene
signaling                                    transcription




                               - Michael Hamblin, Ph.D. – Harvard/MIT
Photomodulation & Human Dermal Papilla Cells
                                               April 2005




                            Effects of light on HDP
                            gene activity in culture &
                            clinical trials

                                VEGF (+1.8)
                                HGF (+2.0)
                                MMP-2 (+2.7)
                                5-AR (0)
FDA 510(k) Clearances
           #K060305, Jan. 18th 2007      650nm               male AGA
           HairMax LaserComb             9 x 5mW             at-home
           Lexington Int’l, LLC


“...indicated to promote hair growth in males with androgenetic alopecia
who have NW Class IIa-V…and does not present any safety issues”
“A Multi-Center, Randomized, Placebo-Controlled Study…”
“treatment group had significantly greater increases in terminal hair
density than… placebo.”



           #K091496, Nov. 13th 2009      650nm               female AGA
           MEP90                         82 x 5mW            in-office
           Midwest RF                                        prescription
FDA 510(k) Clearances
                                     (con’t)

FDA 510(k):     #K091496, Nov 13, 2009
Device:         MEP90 Hair Growth Stimulation System
Manufacturer:   Midwest RF

                                       “ Medically prescribed for the         treatment      of
                                       androgenetic alopecia in females.”
                                       “After 20 treatments, 92% of subjects had increased
                                       hair count ≥10% with 57% demonstrating an increase
                                       of ≥30%”
                                       “After 36th treatment, 97% of the subject population
                                       demonstrated increased hair count of ≥20%, 89%
                                       increased hair count ≥30%, with 57% demonstrating
                                       increase of ≥50%”
                                       “87% of subjects indicated it helped their
                                       condition, 60% reporting slowing of hair loss by 10
                                       weeks, 65% reported their area of hair loss had
                                       gotten smaller.”
                                       In-Office / 650nm / 5mW x 82 diodes
LLLT Dosing Strategy
Wavelength                               Biphasic Dose Response
   635-670nm

Total Power
   # diodes x output (mW)

Treatment Area
Duration (min)
                                   Tuner J, Hode L, Laser Therapy Handbook (2004) Prima Books.

Interval – too short v. too long
Protocol: Device Dependent
LLLT & Hair
Cosmetic Devices
             650 nm

             5mW X 224 Diodes

             80% Duty Cycle

             30 Minutes

             Hands-Free

             Rechargeable/Cordless

             Significant coverage

             High compliance
 LaserCap™
Results Tracking
     Patient History / Intake Questionnaire

     Physical Exam of Scalp & Hair

     Standardized Global Photography

     Video Microscopy

     Combined Cross-sectional Hair Bundle
     Trichometry

     What’s your “HAIR NUMBER?”
Densitometry – Canfield Scientific
LaserCap Results:
Laser Therapy in Females
 25 y/o female

 In-office Laser Hood

 2 / week x 6 months
LLLT x 8 months
   63 y/o female

   Laser Therapy regimen:
       3x/wk x 3 mo
       1-2x/wk since
       Photos after 12mo.
6 Months: At-Home LLLT
24 y/o Female: 3 mos. of LLLT
Male Patient : LLLT x 6 mos
Male Patient: LLLT x 12 mos
References
National Institutes of Health: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS): Q&A Alopecia
Areata
Al-Mutairi N. (2007): 308-nm Excimer laser for the treatment of alopecia areata. Dermatologic Surgery 33(12):1483-1487.
Avram M.R., Leonard R.T.Jr., Epstein E.S., Williams J.L., Bauman A.J. (2007): The current role of laser/light sources in the
treatment of male and female pattern hair loss. Journal of Cosmetic and Laser Therapy 9(1):27-28.
Bernstein E.F. (2005): Hair growth induced by diode laser treatment. Dermatologic Surgery 31(5):584-586.
Chung P.S., Kim Y.C., Chung M.S., Jung S.O., Ree C.K. (2005): The effect of low-power laser on the murine hair growth.
Journal of the Korean Society of Plastic & Reconstructive Surgeons.
Satino J.L., Markou M. (2003): Hair regrowth and increased hair tensile strength using the HairMax LaserComb for low-
level laser therapy. International Journal of Cosmetic Surgery and Aesthetic Dermatology 5(2):113-117.
Vlachos S.P., Kontoes P.P. (2002): Development of terminal hair following skin lesion treatments with an intense pulsed
light source. Aesthetic Plastic Surgery 26(4):303-307.
Waiz M., Saleh A.S., Hayani R., Jubory S.O. (2006): Use of the pulsed infrared diode laser (904 nm) in the treatment of
alopecia areata. Journal of Cosmetic and Laser Therapy 8(1):27-30.
Pontinen, PJ; et.al. Comparative effects of exposure to different light sources (He-Ne laser, InGaAl Diode laser, non-coherent
LED) on skin blood flow of the head, Int J Acupuncture & Electro-therapeutics Research 1996 21(105-118). 670nm
Weiss R., McDaniel D.H., Geronemus R.G., Weiss M., LED Photomodulation induced hair growth stimulations, presented at
ASLMS Annual Meeting – Orlando FL (April 2005), www.interscience.wiley,.com DOI.1002/lsm.20164.
References (con’t)
Bauman Medical Group
             Boca Raton, Florida USA




THANK YOU!
                   doctorb@baumanmedical.com
                  www.twitter.com/DrAlanBauman
                    www.linkedin/in/alanjbauman
Treating Hair Loss w/ Low Level Laser Therapy EMAA-2012 Paris

Treating Hair Loss w/ Low Level Laser Therapy EMAA-2012 Paris

  • 1.
    The Role ofLow Level Laser Therapy in the Medical Management of Androgenetic Alopecia Alan J. Bauman, M.D. Diplomate, American and Int’l Board of Hair Restoration Surgery European Masters in Aesthetic & Anti-Aging Medicine 2nd International Hair Surgery Masters Course October 13th, 2012 Paris, France
  • 2.
    Disclosures The following conflictsof interest are germane to my presentation: NONE LaserSpa at Bauman Medical Group
  • 3.
    Alan J. Bauman,M.D. Bauman Medical Group – Boca Raton, FL (1997) New York Medical College Beth Israel Medical Center – NY Mt. Sinai Medical Center – NY Hair Transplantation – NY American Bd of Hair Restoration Surgery American Hair Loss Association Low Level Laser Therapy (1999)
  • 4.
    Overview AndrogeneticAlopecia Mechanisms of Laser Therapy (LLLT) Role of LLLT in Hair Restoration Laser Therapy Dosing Protocol Our Experience w/ Laser Therapy Practical Concerns
  • 5.
    Androgenetic Alopecia Hereditary :♀♂ HAIR LOSS CAUSES Androgen Receptors 4% Progressive AGA Patterned hair follicle miniaturization Other Shorter/Finer/Thinner/Less Pigmented 96%
  • 6.
    Androgenetic Alopecia Multi-Therapy Medical Management Eliminate/Reduce ‘Triggers’ • Medical conditions, meds, social habits, nutrition, stress, etc. ↓DHT production and/or Androgen Effects • Finasteride, Dutasteride*, Spironolactone* Stimulate Hair Follicles • 2%, 5%, 6%* Minoxidil, 0.03% Bimatoprost*, • Laser Therapy, Phototherapy, PRP Redistribute (Transplant) Permanent Follicles • NeoGraft / FUE – no linear scar Surgically Reduce/Remove Bald Areas • Scalp Reduction/Flaps *off-label
  • 7.
    Low Level LaserTherapy < 500 mW (5mW) Non-chemical 630-670nm (650nm) Non-invasive Non-cutting/burning Non-thermal 3,000 papers No side-effects 8 textbooks Photobiomodulation 6 societies 2 peer-reviewed journals
  • 8.
    Phototherapy/LLLT Concepts Mechanism: Cytochrome–C–Oxidase ↑ATP production Non-ionizing Non-thermal No side-effects Tuner J/Hode L, Laser Therapy, (2004) Prima Books
  • 9.
    growth factor production extracellular matrix deposition near infrared light cell proliferation & motility anti-apoptosis and pro-survival Gene signaling transcription - Michael Hamblin, Ph.D. – Harvard/MIT
  • 10.
    Photomodulation & HumanDermal Papilla Cells April 2005 Effects of light on HDP gene activity in culture & clinical trials VEGF (+1.8) HGF (+2.0) MMP-2 (+2.7) 5-AR (0)
  • 11.
    FDA 510(k) Clearances #K060305, Jan. 18th 2007 650nm male AGA HairMax LaserComb 9 x 5mW at-home Lexington Int’l, LLC “...indicated to promote hair growth in males with androgenetic alopecia who have NW Class IIa-V…and does not present any safety issues” “A Multi-Center, Randomized, Placebo-Controlled Study…” “treatment group had significantly greater increases in terminal hair density than… placebo.” #K091496, Nov. 13th 2009 650nm female AGA MEP90 82 x 5mW in-office Midwest RF prescription
  • 12.
    FDA 510(k) Clearances (con’t) FDA 510(k): #K091496, Nov 13, 2009 Device: MEP90 Hair Growth Stimulation System Manufacturer: Midwest RF “ Medically prescribed for the treatment of androgenetic alopecia in females.” “After 20 treatments, 92% of subjects had increased hair count ≥10% with 57% demonstrating an increase of ≥30%” “After 36th treatment, 97% of the subject population demonstrated increased hair count of ≥20%, 89% increased hair count ≥30%, with 57% demonstrating increase of ≥50%” “87% of subjects indicated it helped their condition, 60% reporting slowing of hair loss by 10 weeks, 65% reported their area of hair loss had gotten smaller.” In-Office / 650nm / 5mW x 82 diodes
  • 13.
    LLLT Dosing Strategy Wavelength Biphasic Dose Response 635-670nm Total Power # diodes x output (mW) Treatment Area Duration (min) Tuner J, Hode L, Laser Therapy Handbook (2004) Prima Books. Interval – too short v. too long Protocol: Device Dependent
  • 14.
  • 15.
    Cosmetic Devices 650 nm 5mW X 224 Diodes 80% Duty Cycle 30 Minutes Hands-Free Rechargeable/Cordless Significant coverage High compliance LaserCap™
  • 16.
    Results Tracking Patient History / Intake Questionnaire Physical Exam of Scalp & Hair Standardized Global Photography Video Microscopy Combined Cross-sectional Hair Bundle Trichometry What’s your “HAIR NUMBER?”
  • 17.
  • 18.
  • 19.
    Laser Therapy inFemales 25 y/o female In-office Laser Hood 2 / week x 6 months
  • 20.
    LLLT x 8months 63 y/o female Laser Therapy regimen: 3x/wk x 3 mo 1-2x/wk since Photos after 12mo.
  • 21.
  • 22.
    24 y/o Female:3 mos. of LLLT
  • 23.
    Male Patient :LLLT x 6 mos
  • 24.
  • 25.
    References National Institutes ofHealth: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS): Q&A Alopecia Areata Al-Mutairi N. (2007): 308-nm Excimer laser for the treatment of alopecia areata. Dermatologic Surgery 33(12):1483-1487. Avram M.R., Leonard R.T.Jr., Epstein E.S., Williams J.L., Bauman A.J. (2007): The current role of laser/light sources in the treatment of male and female pattern hair loss. Journal of Cosmetic and Laser Therapy 9(1):27-28. Bernstein E.F. (2005): Hair growth induced by diode laser treatment. Dermatologic Surgery 31(5):584-586. Chung P.S., Kim Y.C., Chung M.S., Jung S.O., Ree C.K. (2005): The effect of low-power laser on the murine hair growth. Journal of the Korean Society of Plastic & Reconstructive Surgeons. Satino J.L., Markou M. (2003): Hair regrowth and increased hair tensile strength using the HairMax LaserComb for low- level laser therapy. International Journal of Cosmetic Surgery and Aesthetic Dermatology 5(2):113-117. Vlachos S.P., Kontoes P.P. (2002): Development of terminal hair following skin lesion treatments with an intense pulsed light source. Aesthetic Plastic Surgery 26(4):303-307. Waiz M., Saleh A.S., Hayani R., Jubory S.O. (2006): Use of the pulsed infrared diode laser (904 nm) in the treatment of alopecia areata. Journal of Cosmetic and Laser Therapy 8(1):27-30. Pontinen, PJ; et.al. Comparative effects of exposure to different light sources (He-Ne laser, InGaAl Diode laser, non-coherent LED) on skin blood flow of the head, Int J Acupuncture & Electro-therapeutics Research 1996 21(105-118). 670nm Weiss R., McDaniel D.H., Geronemus R.G., Weiss M., LED Photomodulation induced hair growth stimulations, presented at ASLMS Annual Meeting – Orlando FL (April 2005), www.interscience.wiley,.com DOI.1002/lsm.20164.
  • 26.
  • 27.
    Bauman Medical Group Boca Raton, Florida USA THANK YOU! doctorb@baumanmedical.com www.twitter.com/DrAlanBauman www.linkedin/in/alanjbauman